Edwards Lifesciences Corp. engages in the patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into three areas: Transcatheter Heart Valves, Surgical Structural Heart and Critical Care.The Edwards Israel Innovation Center (EIIC) serves as the Israeli R&D center. The office was opened after the acquisition of Percutaneous Valve Technologies in 2003 and it focuses on developing early-stage cardiovascular technologies.
Disclaimer: Shariah screening is based on the latest available financial data. Market conditions and company activities may change. Always conduct your own due diligence.